---
title: "acrivastine - Vasomotor rhinitis"
sidebar: mydoc_sidebar
permalink: acrivastinevasomotorrhinitis.html
toc: false 
---

{% include image.html file="acrivastinevasomotorrhinitis.png" alt="acrivastinevasomotorrhinitis" %}![Path Visualization](/images/acrivastinevasomotorrhinitis.png)

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C043648 | acrivastine | Drug |
| UniProt:P35367 | Histamine H1 receptor | Protein |
| GO:0034776 | response to histamine | BiologicalProcess |
| MESH:D013373 | Substance P | ChemicalSubstance |
| MESH:D020078 | Neurogenic Inflammation | Disease |
| MESH:D012223 | Vasomotor rhinitis | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Acrivastine | DECREASES ACTIVITY OF | Histamine H1 Receptor |
| Histamine H1 Receptor | PARTICIPATES IN | Response To Histamine |
| Response To Histamine | INCREASES ABUNDANCE OF | Substance P |
| Substance P | PARTICIPATES IN | Neurogenic Inflammation |
| Neurogenic Inflammation | CONTRIBUTES TO | Vasomotor Rhinitis |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB:DB09488#mechanism-of-action](https://go.drugbank.com/drugs/DB:DB09488#mechanism-of-action){:target="_blank"}